We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
1.Immunization Practices Advisory Committee.
Diphtheria, tetanus, and pertussis: recommendations for
vaccine use and other preventive measures-recommendations of the
Immunization Practices Advisory Committee (ACIP).
MMWR.
1991;40.Google Scholar
2
2.American Academy of Pediatrics. Report of the
Committee on Infectious Diseases. Elk Grove
Village, Ill: American Academy of
Pediatrics; 1991.Google Scholar
3
3.Blumberg, DA,
Mink, CM, Cherry, JD,
et al. Comparison of an acellular
pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a
whole-cell pertussis-component DTP vaccine in 17- to 24-month-old
children, with measurement of 69 kilodalton outer membrane protein
antibody. J Pediatr:
1990;117:46–51.CrossRefGoogle ScholarPubMed
4
4.Mortimer, EA,
Kimura, M, Cherry, JD,
et al. Protective efficacy of the Takeda
acellular pertussis vaccine combined with diphtheria and tetanus toxoids
following household exposure of Japanese children.
Am J Dis Child.
1990;144:899–904.Google ScholarPubMed